Improving Traumatic Brain Injury Rehabilitation for Patients Worldwide
The is a Massive Unmet Need in Traumatic Brain Injury Rehabilitation
Each year, 27 Million people globally have no solution for long term recovery for TBI. We're developing the first non-invasive therapeutic that accelerates and improves neurological recovery for individuals that have suffered TBI
Who We Are
We are a pre-seed pharmaceutical start-up with a mission of creating therapeutics to allow traumatic brain injury patients to have a faster and fuller recovery. The founder, Lyeth, went through a brain tumor resection at the age of 13 for an astrocytoma brain tumor in his cerebellum. After the extensive and costly rehabilitation process, he is still not fully recovered. He set his life mission to easing the pain of others who are going through similar situations.
